Immuneering Corp (IMRX) — Financial Flexibility Index
Immuneering Corp (IMRX) has a Financial Flexibility Index of -0.92x as of September 2025. Free cash flow of $-11.97 Million (operating CF $-11.98 Million minus capex $7.25K) represents -1% of total liabilities ($13.08 Million). Check Immuneering Corp (IMRX) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Immuneering Corp Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Immuneering Corp across 6 annual periods. See IMRX working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Immuneering Corp (2019–2024)
Year-by-year free cash flow to debt coverage for Immuneering Corp. For the full company profile including market capitalisation, see Immuneering Corp market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.85x | $-54.91 Million | $-55.00 Million | $11.33 Million | ▼ -19.7% |
| 2023 | -4.05x | $-48.63 Million | $-48.97 Million | $12.01 Million | ▼ -16.9% |
| 2022 | -3.46x | $-43.36 Million | $-44.10 Million | $12.52 Million | ▼ -20.7% |
| 2021 | -2.87x | $-30.79 Million | $-30.85 Million | $10.72 Million | ▼ -1100.3% |
| 2020 | -0.24x | $-14.57 Million | $-14.62 Million | $60.90 Million | ▼ -11.6% |
| 2019 | -0.21x | $-4.42 Million | $-4.44 Million | $20.63 Million | — |